= SDRF-Proteomics: Data-Dependent Acquisition (DDA) Template
:sectnums:
:toc: left
:doctype: book
//only works on some backends, not HTML
:showcomments:
//use style like Section 1 when referencing within the document.
:xrefstyle: short
:figure-caption: Figure
:pdf-page-size: A4

//GitHub specific settings
ifdef::env-github[]
:tip-caption: :bulb:
:note-caption: :information_source:
:important-caption: :heavy_exclamation_mark:
:caution-caption: :fire:
:warning-caption: :warning:
endif::[]

[[status]]
== Status of this Template

This document provides a template for annotating Data-Dependent Acquisition (DDA) mass spectrometry experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any core template (human, vertebrates, etc.) to capture DDA-specific metadata.

**Type:** Specialized Template (used in combination with core templates)

**Status:** Draft - This template is under active development and may change significantly.

**Version:** 1.0.0-dev - 2025-01

[[abstract]]
== Abstract

Data-Dependent Acquisition (DDA) is the traditional and most widely used mass spectrometry acquisition strategy for proteomics. In DDA mode, the mass spectrometer:

- Performs a survey scan (MS1) to detect precursor ions
- Selects the most intense precursors (top-N) for fragmentation
- Acquires MS2 spectra for selected precursors
- Uses dynamic exclusion to avoid resampling the same ions

DDA remains the gold standard for discovery proteomics, peptide identification, and building spectral libraries. This template captures the acquisition parameters essential for DDA data analysis and reproducibility.

[[motivation]]
== Motivation

DDA experiments have specific parameters that affect data quality and reproducibility:

1. **Top-N selection**: Number of precursors selected per cycle
2. **Dynamic exclusion**: Duration and settings to avoid resampling
3. **Isolation width**: Width of the precursor isolation window
4. **Intensity threshold**: Minimum intensity for precursor selection
5. **Fractionation**: DDA experiments often use extensive fractionation for deep proteome coverage
6. **Charge state filtering**: Which charge states are selected for fragmentation

These aspects require documentation beyond standard SDRF-Proteomics fields.

[[connections]]
== Connections to Analysis Pipelines

DDA data is typically analyzed using:

- **MaxQuant**: Widely used for label-free and labeling quantification
- **Proteome Discoverer**: Thermo Fisher's commercial platform
- **MSFragger/FragPipe**: High-speed database searching
- **Comet/Percolator**: Open-source search and validation
- **Mascot**: Commercial database search engine
- **PEAKS**: De novo sequencing and database search
- **OpenMS**: Open-source proteomics pipeline

[[additional-ontologies]]
== Additional Ontologies

In addition to the ontologies supported by the core SDRF-Proteomics specification, DDA templates utilize:

- **PSI-MS CV**: For mass spectrometry acquisition terms
- **PRIDE CV**: For proteomics data acquisition methods and fractionation

[[checklist]]
== Checklist

This section defines the metadata columns required and recommended for DDA experiments.

=== Required Columns

The following columns are REQUIRED for DDA experiments in addition to the core SDRF-Proteomics requirements:

|===
|Column Name |Description |Cardinality |Ontology/CV |Example Values

|comment[proteomics data acquisition method]
|Must indicate DDA acquisition
|1
|PRIDE CV
|NT=Data-dependent acquisition;AC=PRIDE:0000627

|comment[precursor mass tolerance]
|Mass tolerance for precursor ions in database search
|1
|Numeric value with unit
|10 ppm, 20 ppm, 0.02 Da

|comment[fragment mass tolerance]
|Mass tolerance for fragment ions in database search
|1
|Numeric value with unit
|0.02 Da, 0.05 Da, 0.5 Da, 20 ppm
|===

=== Recommended Columns

The following columns are RECOMMENDED for DDA experiments:

|===
|Column Name |Description |Cardinality |Ontology/CV |Example Values

|comment[fractionation method]
|Method used to fractionate the sample before MS
|0..1
|PRIDE CV
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564, NT=Strong cation exchange;AC=PRIDE:0000565, no fractionation

|comment[collision energy]
|Collision energy used for fragmentation
|0..1
|Numeric value with unit
|30 NCE, 27 eV, 35 NCE

|comment[dissociation method]
|Fragmentation method used
|0..1
|PSI-MS CV
|NT=beam-type collision-induced dissociation;AC=MS:1000422, NT=electron-transfer dissociation;AC=MS:1000598

|comment[MS2 mass analyzer]
|Mass analyzer used for MS2 acquisition
|0..1
|PSI-MS CV
|NT=Orbitrap;AC=MS:1000484, NT=linear ion trap;AC=MS:1000291

|comment[top N]
|Number of precursors selected per MS1 scan
|0..1
|Numeric value
|10, 15, 20, 40

|comment[isolation window]
|Width of precursor isolation window
|0..1
|Numeric value with unit
|1.6 Th, 2.0 m/z, 1.2 Th

|comment[dynamic exclusion duration]
|Time for dynamic exclusion
|0..1
|Numeric value with unit
|30 s, 60 s, 45 s

|comment[intensity threshold]
|Minimum intensity for precursor selection
|0..1
|Numeric value
|1e4, 5000, 1e5

|comment[charge state]
|Charge states selected for fragmentation
|0..1
|Range or list
|2-6, 2-7, 2+;3+;4+
|===

[[fractionation-methods]]
== Fractionation Methods

DDA experiments often employ fractionation to increase proteome coverage. Common methods:

|===
|Method |PRIDE CV Term |Description |Typical Use

|High-pH reversed-phase
|PRIDE:0000564
|Orthogonal to low-pH RP-LC
|Deep proteome profiling

|Strong cation exchange (SCX)
|PRIDE:0000565
|Charge-based separation
|Complex samples, PTM enrichment

|Strong anion exchange (SAX)
|PRIDE:0000566
|Charge-based separation
|Phosphopeptide fractionation

|Basic reversed-phase
|PRIDE:0000567
|High pH reversed-phase
|General fractionation

|Size exclusion chromatography
|PRIDE:0000568
|Size-based separation
|Protein complex analysis

|Isoelectric focusing (OFFGEL)
|PRIDE:0000569
|pI-based separation
|Complex samples

|No fractionation
|not applicable
|Single-shot analysis
|High-throughput, clinical samples
|===

Document fractionation using `comment[fractionation method]` and indicate fraction numbers with `comment[fraction identifier]`.

[[dda-parameters]]
== DDA Acquisition Parameters

=== Top-N Selection

The number of precursors selected per MS1 scan significantly affects:

- Proteome depth
- Quantification accuracy
- Duty cycle/cycle time

|===
|Top-N Value |Typical Use Case |Trade-offs

|10-15
|Standard discovery
|Good depth and quantification

|20-40
|Deep profiling, fractionated samples
|Maximum identifications, longer cycle

|5-10
|Short gradients, targeted
|Fast cycles, lower depth
|===

=== Dynamic Exclusion

Dynamic exclusion settings prevent repeated sampling of abundant peptides:

|===
|Parameter |Description |Typical Values

|Duration
|Time a precursor is excluded after selection
|30-90 s

|Mass tolerance
|Mass window for exclusion matching
|10 ppm

|Repeat count
|Times a precursor can be selected before exclusion
|1-2
|===

[[example-sdrf]]
== Example SDRF File

A complete example for a fractionated DDA proteomics experiment:

|===
|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[biological replicate] |assay name |technology type |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[cleavage agent details] |comment[fraction identifier] |comment[fractionation method] |comment[technical replicate] |comment[top N] |comment[isolation window] |comment[collision energy] |comment[dynamic exclusion duration] |comment[precursor mass tolerance] |comment[fragment mass tolerance] |comment[dissociation method] |comment[MS2 mass analyzer] |comment[data file]

|liver_sample_001
|homo sapiens
|liver
|normal
|1
|DDA_liver001_F01
|proteomic profiling by mass spectrometry
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|AC=MS:1002038;NT=label free sample
|NT=Q Exactive HF;AC=MS:1002523
|NT=Trypsin;AC=MS:1001251
|1
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|1
|15
|1.6 Th
|30 NCE
|45 s
|10 ppm
|0.02 Da
|NT=beam-type collision-induced dissociation;AC=MS:1000422
|NT=Orbitrap;AC=MS:1000484
|liver001_F01.raw

|liver_sample_001
|homo sapiens
|liver
|normal
|1
|DDA_liver001_F02
|proteomic profiling by mass spectrometry
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|AC=MS:1002038;NT=label free sample
|NT=Q Exactive HF;AC=MS:1002523
|NT=Trypsin;AC=MS:1001251
|2
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|1
|15
|1.6 Th
|30 NCE
|45 s
|10 ppm
|0.02 Da
|NT=beam-type collision-induced dissociation;AC=MS:1000422
|NT=Orbitrap;AC=MS:1000484
|liver001_F02.raw

|liver_sample_001
|homo sapiens
|liver
|normal
|1
|DDA_liver001_F03
|proteomic profiling by mass spectrometry
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|AC=MS:1002038;NT=label free sample
|NT=Q Exactive HF;AC=MS:1002523
|NT=Trypsin;AC=MS:1001251
|3
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|1
|15
|1.6 Th
|30 NCE
|45 s
|10 ppm
|0.02 Da
|NT=beam-type collision-induced dissociation;AC=MS:1000422
|NT=Orbitrap;AC=MS:1000484
|liver001_F03.raw

|liver_sample_002
|homo sapiens
|liver
|hepatocellular carcinoma
|1
|DDA_liver002_F01
|proteomic profiling by mass spectrometry
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|AC=MS:1002038;NT=label free sample
|NT=Q Exactive HF;AC=MS:1002523
|NT=Trypsin;AC=MS:1001251
|1
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|1
|15
|1.6 Th
|30 NCE
|45 s
|10 ppm
|0.02 Da
|NT=beam-type collision-induced dissociation;AC=MS:1000422
|NT=Orbitrap;AC=MS:1000484
|liver002_F01.raw
|===

[[single-shot-example]]
== Single-Shot DDA Example

For high-throughput or clinical samples without fractionation:

|===
|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[biological replicate] |assay name |technology type |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[cleavage agent details] |comment[fraction identifier] |comment[fractionation method] |comment[technical replicate] |comment[top N] |comment[collision energy] |comment[precursor mass tolerance] |comment[fragment mass tolerance] |comment[data file]

|plasma_001
|homo sapiens
|blood plasma
|normal
|1
|plasma001_run1
|proteomic profiling by mass spectrometry
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|AC=MS:1002038;NT=label free sample
|NT=Orbitrap Exploris 480;AC=MS:1003028
|NT=Trypsin;AC=MS:1001251
|1
|no fractionation
|1
|20
|30 NCE
|10 ppm
|0.02 Da
|plasma_001.raw
|===

[[tmt-dda-example]]
== TMT-Labeled DDA Example

For isobaric labeling experiments (TMT, iTRAQ):

|===
|source name |characteristics[organism] |characteristics[disease] |characteristics[biological replicate] |assay name |comment[proteomics data acquisition method] |comment[label] |comment[fraction identifier] |comment[fractionation method] |comment[top N] |comment[MS2 mass analyzer] |comment[data file]

|sample_A_rep1
|homo sapiens
|normal
|1
|TMT_set1_F01
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|TMT126
|1
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|20
|NT=Orbitrap;AC=MS:1000484
|TMT_set1_F01.raw

|sample_B_rep1
|homo sapiens
|cancer
|1
|TMT_set1_F01
|NT=Data-dependent acquisition;AC=PRIDE:0000627
|TMT127N
|1
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
|20
|NT=Orbitrap;AC=MS:1000484
|TMT_set1_F01.raw
|===

NOTE: For TMT experiments, multiple samples share the same raw file. Use `comment[label]` to distinguish channels.

[[best-practices]]
== Best Practices for DDA Annotation

1. **Always specify acquisition method**: Use `comment[proteomics data acquisition method]` with the PRIDE CV term for DDA.

2. **Document fractionation**: Include `comment[fractionation method]` and properly number fractions with `comment[fraction identifier]`.

3. **Report mass tolerances**: Precursor and fragment mass tolerances are essential for data reanalysis.

4. **Include key acquisition parameters**: Top-N, isolation window, and collision energy significantly affect results.

5. **Note dynamic exclusion**: This parameter affects reproducibility between technical replicates.

6. **Specify MS2 analyzer**: Important for understanding resolution and mass accuracy of fragment spectra.

7. **Document fragmentation method**: HCD, CID, ETD, and EThcD produce different fragmentation patterns.

8. **Consider instrument-specific settings**: Different platforms may have unique parameters worth documenting.

[[template-file]]
== Template File

The DDA SDRF template file is available in this directory:

- link:dda-acquisition-template.sdrf.tsv[dda-acquisition-template.sdrf.tsv]

[[validation]]
== Validation

DDA SDRF files should be validated using the sdrf-pipelines tool:

[source,bash]
----
pip install sdrf-pipelines
parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv
----

NOTE: DDA-specific validation rules are under development.

[[authors]]
== Authors and Maintainers

This template was developed by the SDRF-Proteomics community.

For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository].

[[references]]
== References

- Michalski A, et al. (2011) More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. Journal of Proteome Research.
- Hebert AS, et al. (2014) The one hour yeast proteome. Molecular & Cellular Proteomics.
- Kelstrup CD, et al. (2018) Performance evaluation of the Q Exactive HF-X for shotgun proteomics. Journal of Proteome Research.
- Bekker-Jensen DB, et al. (2017) An optimized shotgun strategy for the rapid generation of comprehensive human proteomes. Cell Systems.
